Period of time： 2014年12期
Publisher： Informa Healthcare
Founded in： 1992
Total resources： 167
ISSN： 1354-3784
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Investigational Drugs,volume 12,issue 12
Menu
Novel chemotherapeutic agents for the treatment of glioblastoma multiforme
By Jendrossek Verena,Belka Claus,Bamberg Michael in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.
Access to resources
Recommend
Therapeutic potential of thiazolidinediones as anticancer agents
By Panigrahy Dipak,Shen Lucy Q,Kieran Mark W,Kaipainen Arja in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived
By O’Neil Bert H,Goldberg Richard M in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.Novel FLT3 tyrosine kinase inhibitors
By Levis Mark,Small Donald in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.Update on acute coronary syndromes and implications for therapy
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.DNA methylation in haematological malignancies: the role of decitabine
By Hennessy Bryan T,Garcia-Manero Guillermo,Kantarjian Hagop M,Giles Francis J in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.13th European Respiratory Society Annual Congress
By Tsaprouni Loukia,Adcock Ian M in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.By Gerber Hans-Peter in (2003)
Expert Opinion on Investigational Drugs,volume 12,issue 12 , Vol. 12, Iss. 12, 2003-12 , pp.